PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology and Bone-Marrow Transplantation, Sheba Medical Center, Tel-Hashomer, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.\', \'The Infectious Diseases Unit, Sheba Medical Center, Tel-Hashomer, Israel.\', \'Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel.\', \'Central Virology Laboratory, Ministry of Health and Sheba Medical Center, Tel-Hashomer, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/bjh.17918
?:hasPublicationType
?:journal
  • British journal of haematology
is ?:pmid of
?:pmid
?:pmid
  • 34713441
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.036
?:rankingScore_hIndex
  • 169
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all